Brief

SSHAP Briefing

Key Considerations: Effective Vaccine Rollout and Uptake in Sierra Leone

Published on 15 May 2024

Sierra Leone received its first shipment of 550,000 malaria vaccines in December 2023, marking a milestone for public health in a country that sees over two million hospital visits for malaria annually. Over the last 20 years, routine childhood vaccination in Sierra Leone has increased significantly; DTP (diphtheria, tetanus and pertussis) coverage went from 64% in 2004 to 91% in 2022, while measles went from 60% in 2015 to 73% in 2022. Sierra Leone has also implemented emergency vaccination programmes, such as experimental Ebola vaccines and the more recent COVID-19 vaccines. However, major crises – such as the 1991-2002 civil war and the Ebola epidemic – have resulted in significant drops in vaccine coverage.

This brief draws on evidence from academic and grey literature, proposing key considerations for ongoing vaccination efforts – including the hepatitis vaccine and the new malaria vaccine (RTS,S/AS01 (RTS,S)). It offers insights on how best to address these considerations when planning equitable vaccine campaigns for new infections. This will enable UNICEF and health system stakeholders including the Expanded Program on Immunization, the Directorate of Primary Healthcare, and the District Health Management Teams to plan inclusive and equitable vaccine programming.

Cite this publication

Conteh, A., Mansaray, A., Schmidt-Sane, M., and Enria, L. (2024). Key considerations: Effective vaccine rollout and uptake in Sierra Leone. Social Science in Humanitarian Action (SSHAP). www.doi.org/10.19088/SSHAP.2024.011

Authors

Megan Schmidt-Sane

Research Fellow

Publication details

published by
Institute of Development Studies
doi
www.doi.org/10.19088/SSHAP.2024.011
language
English

Share

About this publication

Region
Sierra Leone

Related content

Brief

Key considerations: Home-based care for mpox in Central and East Africa

SSHAP Briefing

Diane Duclos & 3 others

3 June 2025

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.